Literature DB >> 10673687

Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases.

A Schulenburg, P Kalhs, N Worel, P Höcker, P Knöbl, H T Greinix.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10673687     DOI： 10.1038/sj.bmt.1702124

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  1 in total

1.  High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells.

Authors:  A K Blystad; H Holte; S Kvaløy; E Smeland; J Delabie; G Kvalheim
Journal:  Bone Marrow Transplant       Date:  2001-11       Impact factor: 5.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.